Compounds > amikacin
Page last updated: 2024-08-23

amikacin and Disease Models, Animal

amikacin has been researched along with Disease Models, Animal in 106 studies

Research

Studies (106)

TimeframeStudies, this research(%)All Research%
pre-19906 (5.66)18.7374
1990's21 (19.81)18.2507
2000's17 (16.04)29.6817
2010's41 (38.68)24.3611
2020's21 (19.81)2.80

Authors

AuthorsStudies
Chauffour, A; Jarlier, V; Ji, B; Lefrançois, S; Robert, J1
Bai, J; Ding, M; Li, Q; Liang, Q; Liang, S; Wang, G; Yan, X; Zhang, B; Zhang, F; Zhou, Y1
Ayral, M; Dedeoğlu, S1
Deddens, BL; Engiles, JB; Frink, A; Gilbertie, JM; Hickok, NJ; Jacob, ME; Ruthel, G; Schaer, TP; Schnabel, LV; Schubert, AG; Seiler, GS; Stefanovski, D; Stowe, DM1
Barzegar, KEF; Barzegar, PEF; Farjanikish, G; Hayati, FZ; Ranjbar, R; Tahmasebi, E; Tebyaniyan, H; Yazdanian, M1
A Katouah, H; Acker, M; Al Hadi, R; Ali, M; Alserihi, R; Alyami, J; Alzahrani, E; Amirazodi, M; Amrillah, T; Andreassen, OA; Ardiccioni, C; Ask, H; Atzori, C; Ayorech, Z; Azambuja, JH; Azmi, R; Badem, S; Balci, AB; Bali, H; Baranova, NS; Barantsevich, ER; Barocci, S; Bauer, RJ; Bauermeister, JA; Bazhenova, TA; Biagetti, G; Bigdeli, F; Bonar, EE; Bouloumis, T; Bu, Y; Cai, Z; Cakiroglu, B; Canetto, SS; Cao, J; Caucci, S; Cerbo, I; Chen, C; Chen, J; Chen, Q; Chen, Y; Cheng, B; Cheng, X; Chinappi, M; Choya, A; Cicconardi, F; Cipolletta, S; Colasurdo, G; Costabile, BK; Coughlin, LN; Crippa, P; D'Agostino, M; D'Annessa, I; Daryanoosh, F; Das, R; Davey Smith, G; Davidson, BR; Davies, NM; Davis, TME; Davis, WA; de Rivas, B; Demir, D; Deng, Z; Dhanya, TM; Di Marino, D; Divya, KM; Dong, N; Drinkwater, JJ; Ekholuenetale, M; El-Bindary, AA; El-Bindary, MA; El-Desouky, MG; Elsayed, H; Ema, K; Endraswari, PD; Entilli, L; Ettl, T; Eyado, A; Fan, X; Fang, W; Farina, M; Florimbio, AR; Fowobaje, KR; Gaeini, A; Gao, XM; Gao, Y; Ghaemi, R; Ghelardi, E; Gilmutdinov, IF; Gochicoa-Rangel, L; Goncu, MT; Gözüküçük, R; Grammatikopoulos, P; Gu, Y; Guan, ZJ; Gucu, A; Guldberg, R; Gungor, O; Guo, W; Gutiérrez-Ortiz, JI; Guzmán-Boulloud, N; Guzmán-Valderrábano, C; Głuszko, A; Hama, A; Hamada, M; Han, J; Hashimoto, T; Havdahl, A; Hayashita, T; He, X; Helgeland, Ø; Hinck, AP; Hinck, CS; Holtzapple, M; Hou, Y; Howe, LD; Hu, B; Hu, H; Huang, L; Huang, Z; Hughes, AM; Hussain, G; Ibidoja, OJ; Ichikawa, D; Imber, C; Islam, MR; Iype, S; Jaber, J; Jacobs, R; Jafry, AT; Ji, L; Ji, X; Jiang, L; Jiang, Y; Jie, HFM; Jie, HM; Johansen, MP; Johansson, S; Juan, LX; Juan, W; Kahraman, N; Kallinger, I; Kang, H; Karakulova, YV; Kärmer, T; Kataoka, S; Kato, K; Kawashima, N; Kazim, AH; Khalil, MR; Kitazawa, H; Klimesova, YM; Kojima, S; Kose, M; Kostakis, ID; Koushkie Jahromi, M; Krishna, GA; Krizova, D; La Teana, A; Lan, K; Li, J; Li, JZ; Li, M; Li, R; Li, S; Li, Y; Li, Z; Liu, H; Liu, J; Liu, KG; Liu, L; Liu, Q; Liu, T; Liu, X; Lomachenko, KA; López-Fonseca, R; Ludwig, N; Luo, A; Luo, L; Luo, Y; Lupetti, A; M El-Metwaly, N; Ma, K; Maemura, R; Magnus, P; Manakin, YV; Mancia, F; Mashood, LO; Matsumoto, K; Mehrabi, A; Meier, JK; Mekonnen, Y; Mencarelli, D; Menzo, S; Mikagi, A; Mironov, VS; Misawa-Suzuki, T; Miwata, S; Mizuta, Y; Mohanan, PV; Mondal, J; Morici, P; Morita, K; Morozzo Della Rocca, B; Morris, T; Morsali, A; Morzhukhina, MV; Motta, S; Muramatsu, H; Naidu, R; Narita, A; Narita, K; Nasralla, D; Nemcokova, M; Netukova, M; Nishikawa, E; Nishio, N; Niu, X; Niu, Y; Njølstad, P; Notarstefano, V; Nugroho, MA; Nørgård, BM; Okuno, Y; Olokede, O; Ong, SP; Osailan, A; Ouyang, Z; Ozyazicioglu, AF; Pan, F; Parui, A; Paul, R; Pavoni, E; Payne, TE; Peng, X; Pérez-Padilla, R; Perta, N; Peter, SC; Pierantoni, L; Pietrowska, M; Pissanou, T; Pollok, JM; Prasetio, A; Putra, FS; Qiang, C; Qiao, L; Qutob, HMH; Raptis, DA; Razzo, BM; Reichborn-Kjennerud, T; Reichert, TE; Remigio-Luna, A; Rexha, J; Rivani, E; Rizzato, C; Romagnoli, A; Rossolini, GM; Sa, LY; Saad, RA; Sakaguchi, H; Salesi, M; Salsabilla, Z; Sanderson, E; Sanderson, P; Savitha, DP; Schulz, D; Seker, IB; Selvaganapathy, PR; Sha, D; Shah, SF; Shaikhomar, OA; Sharma, D; Shi, C; Shi, P; Shrotri, A; Sidiq, DH; Simonov, SV; Singh, AK; Song, C; Song, T; Spanier, G; Spoerl, S; Staropoli, A; Statsenko, ME; Steinhauer, S; Stosic, A; Studeny, P; Sugaya, T; Sun, S; Sun, X; Sunbul, SA; Supandi, AR; Suzuki, K; Suzuki, Y; Szczepański, MJ; Takahashi, Y; Taniguchi, R; Tao, Y; Tesli, M; Thirión-Romero, I; Tong, D; Trucchi, E; Tsuchido, Y; Turchetti, C; Turkina, SV; Turner, AW; Uldbjerg, N; Vinale, F; Wakamatsu, M; Walton, MA; Wang, C; Wang, Q; Wang, W; Wang, Y; Wang, Z; Wehberg, S; Wei, ZL; Wen, B; Whiteside, TL; Whittingham, MS; Widodo, ADW; Widłak, P; Wright, AI; Wu, H; Wu, Y; Wu, YL; Xiang, LG; Xiao, G; Xie, B; Xie, L; Xin, H; Xiong, J; Xiong, X; Xu, C; Xu, S; Yagubskii, EB; Yakushev, IA; Yang, H; Yang, J; Yao, J; Yao, ZX; Ye, J; Yerneni, SS; Yirgu, A; Yoshida, N; Yoshida, T; Young, SD; Yu, DN; Yuksel, A; Zac, J; Zac, S; Zarifkar, AH; Zhai, Y; Zhang, F; Zhang, H; Zhang, JW; Zhang, L; Zhang, Q; Zhang, X; Zhang, Y; Zhao, D; Zhao, J; Zhao, M; Zheng, D; Zheng, J; Zhou, G; Zhou, H; Zhu, P; Zhu, T; Zhu, Y; Zimmerman, MA; Zou, X1
Rishi, P; Sharma, A; Singh, R1
Camci, ED; Gibson, RM; Kirkwood, NK; Kitcher, SR; Kros, CJ; Raible, DW; Redila, VA; Richardson, GP; Rubel, EW; Simon, JA; Wu, P1
Bate, PNN; Chiwala, G; Fang, C; Guan, P; Hameed, HMA; Hu, J; Khan, SA; Liu, J; Liu, Z; Mugweru, JN; Tan, S; Tan, Y; Wang, B; Yusuf, B; Zhang, T; Zhong, N1
Abdulkareem, A; Al-Alak, S; Al-Joofy, I; Al-Kakei, S; Al-Oqaili, R; Chaloob, A; Hussein, B; Mahdi, L; Mahdi, N; Musafer, H; Mussa, A; Rasool, K; Salman, I; Taher, N; Zwain, L1
Chopra, S; Das, S; Dasgupta, A; Karaulia, P; Pandey, AK; Pandey, M; Singh, AK; Soni, I; Thakare, R1
Arslan, IB; Aslan, A; Aslan, GG; Cukurova, I; Gokalp, S; Mercan, GC; Vatansever, S1
Cai, Y; Wang, J; Wang, R; Yang, D1
Awais, R; Beenken, KE; Boles, LR; Haggard, WO; Jessica, AJ; Smeltzer, MS1
Abdelmonem, S; Abdelsameea, AA; El-Anwar, MW; Galhoom, D; Nada, E1
Aguilera Xiol, E; Amaro, R; Antonelli, M; Artigas, A; Blasi, F; Bobi, J; Bringué, J; Carbonara, M; Chiurazzi, C; Comaru, T; Comino Trinidad, O; De Rosa, F; Fernandez-Barat, L; Fuster, C; Li Bassi, G; Marti, JD; Montgomery, AB; Motos, A; Nicolau, DP; Pelosi, P; Ramirez, J; Ranzani, OT; Rigol, M; Rinaudo, M; Saco, MA; Senussi, T; Torres, A; Yang, H1
Brezun, JM; Cazals, Y; Edge, A; Lahlou, H; Lopez-Juarez, A; Ripoll, C; Wang, Q; Zine, A1
Barber, AE; Debnath, I; Dhakal, BK; Kulesus, RR; Mulvey, MA; Norton, JP; Ott, EM1
Bělohlávek, J; Bouček, T; Fichtl, J; Hodková, G; Huptych, M; Kittnar, O; Linhart, A; Mlček, M; Mrázek, V; Springer, D; Zima, T1
Ajalloueyan, M; Askari, A; Hasanalifard, M; Kaka, GR; Mesbahzadeh, B1
Aksoy, F; Dogan, R; Eren, SB; Hüseyinbas, Ö; Ozturan, O; Pektas, A; Veyseller, B1
Bermudez, LE; Gupta, R; Neville, ME; Rose, SJ1
Asci, H; Bayram, D; Candan, IA; Cankara, FN; Ilhan, I; Saygin, M; Yesilot, S1
Kuijper, EJ; van Ingen, J1
Aksoy, F; Dogan, R; Ozturan, O; Ozturk, B; Veyseller, B; Yenigun, A; Yildirim, YS1
Birkun, AA; Fedosov, MI; Krivorutchenko, YL; Kubyshkin, AV; Novikov, NY; Postnikova, ON; Snitser, AA1
Agudelo, M; Rodriguez, CA; Vesga, O; Zuluaga, AF1
Beenken, KE; Courtney, HS; Haggard, WO; Jennings, JA; Parker, AC; Smeltzer, MS; Smith, JK1
Altuntas, I; Cetin, H; Kara, A; Kaya, S; Metin Ciris, I; Oktem, F1
Alp, HH; Ari, E; Basbugan, Y; Bayram, I; Bektas, H; Bulut, G; Erten, R1
Avcı, D; Erkan, M; Güleç, Ş; Gündoğdu, R; Güneş, MS; Karabulut, D; Kökoğlu, K; Sönmez, MF1
Hasegawa, H; Izumikawa, K; Kaku, N; Kosai, K; Miyazaki, T; Morinaga, Y; Mukae, H; Takeda, K; Uno, N; Yanagihara, K1
Chen, ZH; Li, ZC; Luo, ZH; Wang, H1
Cediel, R; Contreras, J; Murillo-Cuesta, S; Varela-Nieto, I1
Hou, J; Ledesma, KR; Prince, RA; Singh, R; Tam, VH; Yuan, Z1
Antony, VB; Bellew, BF; Brown, S; Faruqi, I; Mohammed, KA; Montes-Worboys, A; Moudgil, B; Regev, D; Sharma, P1
Haggard, WO; Noel, SP; Stinner, DJ; Watson, JT; Wenke, JC1
Brescini, L; Cirioni, O; Gabrielli, E; Ghiselli, R; Giacometti, A; Guerrieri, M; Minardi, D; Muzzonigro, G; Orlando, F; Rimini, M; Silvestri, C1
Asseray, N; Bugnon, D; Caillon, J; Dubé, L; Jacqueline, C; Potel, G1
Dimopoulou, D; Galanakis, E; Kofteridis, DP; Maraki, S; Ntaoukakis, M; Samonis, G; Sarchianaki, E; Spathopoulou, T1
Beytur, A; Cinar, K; Dogan, Z; Ekinci, N; Ekincioglu, Z; Kose, E; Soysal, H; Turkoz, Y; Vardi, N1
Hatano, M; Ito, M; Kelly, JB; Yoshizaki, T1
Chen, ZT; Guo, WW; Li, DK; Li, L; Liu, HZ; Ren, LL; Sun, JH; Wu, N; Xing, GQ; Yang, SM; Zhao, LD1
Bentoucha, A; Dega, H; Grosset, J; Jarlier, V; Robert, J1
Ferrari, F; Goldstein, I; Marquette, CH; Nicolas-Robin, A; Rouby, JJ; Wallet, F1
Engelbert, M; Grasbon, T; Kampik, A; Klauss, V; Mette, M; Miño de Kaspar, H; Schulze-Schwering, M; Ta, CN; Thiel, M1
Engelbert, M; Grasbon, T; Kampik, A; Klauss, V; Miño de Kaspar, H; Schulze-Schwering, M; Ta, CN; Thiel, M1
Acet, A; Koc, M; Ozer, MK; Parlakpinar, H; Polat, A; Turkoz, Y; Vardi, N1
Dick, JD; Hose, S; Hyon, JY; Joo, MJ; O'Brien, TP; Sinha, D1
Bernabeu-Wittel, M; García-Curiel, A; Ibáñez-Martínez, J; Jiménez-Mejías, ME; Pachón, J; Pachón-Ibáñez, ME; Pichardo, C1
Bramhne, HG; Chhibber, S; Sharma, S; Toky, V1
Felici, A; Guerrini, M; Marchetti, F; Piccoli, L1
Bedwell, DM; Du, M; Fan, L; Keeling, KM; Kovaçs, T; Liu, X; Sorscher, E1
Forge, A; Nevill, G; Taylor, RR1
De Kaspar, HM; Engelbert, M; Kampik, A; Mette, M; Ta, CN; Thiel, M1
Fasching, CE; Gerding, DN; Moody, JA; Peterson, LR2
Lynch, G; McAvinchey, DJ; McCollum, PT1
Davis, SD; Hyndiuk, RA; Sarff, LD1
Anastassiadou, H; Dassiou, M; Samonis, G1
Carbon, C; Farinotti, R; Goldstein, F; Gutmann, L; Mainardi, JL; Mohler, J; Zhou, XY1
Hu, C; Lu, Y; Song, B; Wei, H; Yang, J; Yun, G; Zeng, S; Zhang, Y; Zou, W1
Berlin, OG; Bruckner, DA; Helm, CJ; Holland, GN; Lin, R1
Cunha, BA; Domenico, P; Straus, DC; Woods, DE1
Aguilar, E; el-Massry, A; Gardner, S; Mandell, BA; Meredith, TA; Sawant, A1
Bancroff, G; Bucke, W; Ehlers, S; Fortmann, L; Hahn, H; Hänsch, H; Leitzke, S; Müller, R; Smith, D1
Chiang, SM; Dorr, RT; Grayson, JB; Hersh, EM; Oka, M; Petersen, EA; Proffitt, RT1
Alfaro, DV; Barton, CP; Beverly, DT; Brucker, AJ; Hudson, SJ; Kasowski, EJ; King, LP; Lopez, JD1
Elkhaïli, H; Jehl, F; Levêque, D; Linger, L; Monteil, H; Niedergang, S; Peter, JD; Pompei, D; Salmon, J; Salmon, Y; Thierry, RC1
D'Amico, DT; Ng, EW1
Jacolot, A; Mimoz, O; Padoin, C; Petitjean, O; Samii, K; Tod, M1
Elhelali, N; Jacolot, A; Laurent, F; Léotard, S; Mimoz, O; Nordmann, P; Petitjean, O; Samii, K1
Atamer-Simsek, S; Eroglu, L; Güc, O; Olmez-Salvarli, H1
Bryskier, A; Carbon, C; Farinotti, R; Joly-Guillou, ML; Wolff, M1
Baron, D; Bugnon, D; Caillon, J; Dube, L; Kergueris, MF; Le Conte, P; Navas, D; Potel, G; Robaux, MA1
MacGregor, RR1
Ciebieda, I; Denys, A; Ferszt, T; Korczak, E1
Cynamon, MH; DeStefano, MS; Klemens, SP1
Bugaeva, OK; Kasatkina, IV; Makarovskaia, LN; Shcherbaniuk, AI1
Berlin, OG; Bruckner, DA; Holland, GN; Paschal, JF; Phinney, RB; Stevens, RK1
Auvergnat, JC; Dabernat, H; Froidefond, S; Lemozy, J; Marchou, B; Saivin, S1
Harrison, RV; Mount, RJ; Nagasawa, A; Smith, DW; Stanton, S1
Pavlovich, NV; Ryzhko, IV; Tynkevich, NK1
Bermudez, LE; Cogger, J; Lin, JP; Yau-Young, AO; Young, LS1
Dougherty, SH1
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV1
Azad, M; Gupta, S; Khandelwal, M; Manglani, K; Upadhyay, P1
Chang, Y; Jiang, X; Li, G; Ma, R; Wang, C; Wu, Y; Zheng, S; Zhu, J1
Edwards, CM; Edwards, JR; Gooding, S; Javaid, MK; Leung, SK; Lwin, ST; Nador, G; Olechnowicz, SWZ; Ramasamy, K; Rao, SR; Weivoda, MM1
Xiao, WZ; Zhang, L1
Chabry, J; Gautier, N; Nicolas, S; Pisani, DF; Rochet, N1
Liu, B; Liu, CL; Liu, J; Wang, JG; Yan, HJ1
Bunting, M; Chan, KH; Chan, PK; Chu, LW; Chung, SK; Festenstein, R; Iyaswamy, A; Jian, M; Kumar Durairajan, SS; Kwan, JS; Lam, KS; Leung, KM; Li, M; Ma, OK; Ng, RC; Senthilkumar, K; Zhou, GJ1
Gong, Z; Gu, D; Han, Y; He, D; Ren, H; Shi, Y; Xia, T; Yang, J; Zeng, C1
Gao, P; Han, Y; Jiang, N; Sun, L; Xiong, S; Zhao, H1
Li, Y; Ruan, C; Song, B; Xue, W; Zhao, J1
Akimoto, M; Koshikawa, N; Nagase, H; Takenaga, K1
Akhyari, P; Boeken, U; Chekhoeva, A; Immohr, MB; Jenke, A; Kistner, J; Lichtenberg, A; Miyahara, S; Yazdanyar, M1
Hu, P; Ji, H; Liu, H; Liu, S; Liu, Y; Luo, E; Zhao, Q1
Bouslama, R; Forsgård, R; Groop, PH; Lehto, M; Lehtonen, E; Lehtonen, S; Lindfors, S; Mannerla, M; Mirtti, T; Nisen, H; Polianskyte-Prause, Z; Salmenkari, H; Tienari, J1
Binienda, A; Fichna, J; Kordek, R; Majchrzak, K; Małecka-Panas, E; Salaga, M; Zatorski, H; Zielińska, M1
Chen, Y; Duan, Y; Han, J; Li, Q; Li, X; Li, Y; Liu, L; Liu, Y; Ma, C; Miao, QR; Sun, L; Yang, X; Yu, M; Zeng, P; Zhang, R; Zhu, Y1
Asano, Y; Fang, F; Hong, W; Lakota, K; Sato, S; Sodin-Semrl, S; Taniguchi, T; Varga, J; Yamashita, T; Yoshizaki, A; Zhou, X1
Bayer, P; Béchade, C; Chabry, J; Debayle, D; Gay, AS; Guyon, A; Heurteaux, C; Maroteaux, L; Nicolas, S1
Liang, F; Lu, J; Shao, A; Shi, L; Sun, Z; Xu, W; Yu, J; Zhang, J; Zheng, J1
Holland, WL; Scherer, PE1

Reviews

3 review(s) available for amikacin and Disease Models, Animal

ArticleYear
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
    Medicina clinica (English ed.), 2022, Dec-23, Volume: 159, Issue:12

    Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Psychological; Adolescent; Adsorption; Adult; Aged; Alcohol Drinking; Alzheimer Disease; Amikacin; Ammonia; Anaerobiosis; Animals; Anorexia; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Anxiety; Aptamers, Nucleotide; Asthenia; Attention Deficit Disorder with Hyperactivity; Bacterial Proteins; Beryllium; beta-Lactamases; Biofuels; Biomass; Biosensing Techniques; Bismuth; Blister; Body Mass Index; Body Surface Area; Boronic Acids; Brain; Breast Neoplasms; Butyrylcholinesterase; Cannabis; Carbapenems; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carboxylic Acids; Carcinoma, Hepatocellular; Cardiovascular Diseases; Carnitine; Case-Control Studies; Catalysis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; China; Cholinesterase Inhibitors; Clarithromycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Cohort Studies; Colistin; Colitis; Colon; Coloring Agents; Coronary Artery Bypass; Creatinine; Crystalloid Solutions; Cytokines; Depression; Dextran Sulfate; Dextrans; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Diarrhea; Dietary Supplements; Diphenhydramine; Disease Models, Animal; Disease Outbreaks; Double-Blind Method; Doxorubicin; Drosophila; Drug Tapering; Dysbiosis; Electrons; Escherichia coli; Extracellular Vesicles; Fatigue; Female; Fermentation; gamma-Cyclodextrins; Gastrointestinal Microbiome; Glucose; Graft Survival; Graft vs Host Disease; Head and Neck Neoplasms; Heart Arrest, Induced; Hematopoietic Stem Cell Transplantation; High-Intensity Interval Training; Hippocampus; Humans; Hydrogen-Ion Concentration; Hypertension; Incidence; Interferon-gamma; Italy; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Lactoferrin; Larva; Length of Stay; Lignin; Liver; Liver Neoplasms; Liver Transplantation; Living Donors; Low Back Pain; Lung; Lung Volume Measurements; Macrophages; Male; Melphalan; Men; Mendelian Randomization Analysis; Meropenem; Methane; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mitochondrial Proteins; Molecular Docking Simulation; Molecular Structure; Mothers; Motivation; Mycoplasma; Mycoplasma hominis; Mycoplasma Infections; NAD; Nanocomposites; Nanoparticles; Nanotubes, Carbon; Naproxen; Neovascularization, Pathologic; Neurons; Nitrates; Nucleolin; Opuntia; Paratyphoid Fever; Phenotype; Phosphatidylinositol 3-Kinases; Phytochemicals; Plant Extracts; Pregnancy; Prevalence; Prospective Studies; Proto-Oncogene Proteins c-akt; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Wistar; Resveratrol; Retrospective Studies; Rifampin; Risk Factors; RNA, Messenger; Selenium; Sleep; Social Behavior; Soil; Soil Pollutants; Squamous Cell Carcinoma of Head and Neck; Staphylococcus aureus; Structure-Activity Relationship; Suicidal Ideation; Suicide; Superoxide Dismutase-1; Surveys and Questionnaires; Swimming; Syndrome; Tannins; Temperature; Transforming Growth Factor beta; Transplantation Conditioning; Treatment Outcome; Triple Negative Breast Neoplasms; Troponin T; Tumor Microenvironment; United Kingdom; Ureaplasma; Ureaplasma urealyticum; Urinary Tract Infections; Viscum; Waste Disposal Facilities; Wastewater; Water; Water Pollutants, Chemical; Wolfiporia; Young Adult

2022
Drug susceptibility testing of nontuberculous mycobacteria.
    Future microbiology, 2014, Volume: 9, Issue:9

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Humans; Lung Diseases; Macrolides; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium kansasii; Nontuberculous Mycobacteria

2014
Role of amikacin in the management of intra-abdominal sepsis.
    The American journal of medicine, 1985, Jul-15, Volume: 79, Issue:1A

    Topics: Abdomen; Abscess; Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; Disease Models, Animal; Drug Resistance, Microbial; Drug Therapy, Combination; Gram-Negative Bacteria; Humans; Kanamycin; Lactams; Peritonitis; Wound Infection

1985

Trials

1 trial(s) available for amikacin and Disease Models, Animal

ArticleYear
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
    Medicina clinica (English ed.), 2022, Dec-23, Volume: 159, Issue:12

    Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Psychological; Adolescent; Adsorption; Adult; Aged; Alcohol Drinking; Alzheimer Disease; Amikacin; Ammonia; Anaerobiosis; Animals; Anorexia; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Anxiety; Aptamers, Nucleotide; Asthenia; Attention Deficit Disorder with Hyperactivity; Bacterial Proteins; Beryllium; beta-Lactamases; Biofuels; Biomass; Biosensing Techniques; Bismuth; Blister; Body Mass Index; Body Surface Area; Boronic Acids; Brain; Breast Neoplasms; Butyrylcholinesterase; Cannabis; Carbapenems; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carboxylic Acids; Carcinoma, Hepatocellular; Cardiovascular Diseases; Carnitine; Case-Control Studies; Catalysis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; China; Cholinesterase Inhibitors; Clarithromycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Cohort Studies; Colistin; Colitis; Colon; Coloring Agents; Coronary Artery Bypass; Creatinine; Crystalloid Solutions; Cytokines; Depression; Dextran Sulfate; Dextrans; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Diarrhea; Dietary Supplements; Diphenhydramine; Disease Models, Animal; Disease Outbreaks; Double-Blind Method; Doxorubicin; Drosophila; Drug Tapering; Dysbiosis; Electrons; Escherichia coli; Extracellular Vesicles; Fatigue; Female; Fermentation; gamma-Cyclodextrins; Gastrointestinal Microbiome; Glucose; Graft Survival; Graft vs Host Disease; Head and Neck Neoplasms; Heart Arrest, Induced; Hematopoietic Stem Cell Transplantation; High-Intensity Interval Training; Hippocampus; Humans; Hydrogen-Ion Concentration; Hypertension; Incidence; Interferon-gamma; Italy; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Lactoferrin; Larva; Length of Stay; Lignin; Liver; Liver Neoplasms; Liver Transplantation; Living Donors; Low Back Pain; Lung; Lung Volume Measurements; Macrophages; Male; Melphalan; Men; Mendelian Randomization Analysis; Meropenem; Methane; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mitochondrial Proteins; Molecular Docking Simulation; Molecular Structure; Mothers; Motivation; Mycoplasma; Mycoplasma hominis; Mycoplasma Infections; NAD; Nanocomposites; Nanoparticles; Nanotubes, Carbon; Naproxen; Neovascularization, Pathologic; Neurons; Nitrates; Nucleolin; Opuntia; Paratyphoid Fever; Phenotype; Phosphatidylinositol 3-Kinases; Phytochemicals; Plant Extracts; Pregnancy; Prevalence; Prospective Studies; Proto-Oncogene Proteins c-akt; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Wistar; Resveratrol; Retrospective Studies; Rifampin; Risk Factors; RNA, Messenger; Selenium; Sleep; Social Behavior; Soil; Soil Pollutants; Squamous Cell Carcinoma of Head and Neck; Staphylococcus aureus; Structure-Activity Relationship; Suicidal Ideation; Suicide; Superoxide Dismutase-1; Surveys and Questionnaires; Swimming; Syndrome; Tannins; Temperature; Transforming Growth Factor beta; Transplantation Conditioning; Treatment Outcome; Triple Negative Breast Neoplasms; Troponin T; Tumor Microenvironment; United Kingdom; Ureaplasma; Ureaplasma urealyticum; Urinary Tract Infections; Viscum; Waste Disposal Facilities; Wastewater; Water; Water Pollutants, Chemical; Wolfiporia; Young Adult

2022

Other Studies

103 other study(ies) available for amikacin and Disease Models, Animal

ArticleYear
Curing Mycobacterium ulcerans infection in mice with a combination of rifampin-streptomycin or rifampin-amikacin.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:2

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Therapy, Combination; Female; Mice; Mice, Inbred BALB C; Mycobacterium Infections, Nontuberculous; Mycobacterium ulcerans; Rifampin; Streptomycin; Treatment Outcome

2007
Carbapenem-resistant K. pneumoniae exhibiting clinically undetected amikacin and meropenem heteroresistance leads to treatment failure in a murine model of infection.
    Microbial pathogenesis, 2021, Volume: 160

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Carbapenems; Disease Models, Animal; Klebsiella pneumoniae; Meropenem; Mice; Microbial Sensitivity Tests; Treatment Failure

2021
Protective effect of ethyl pyruvate on amikacin-induced ototoxicity in rats.
    European review for medical and pharmacological sciences, 2022, Volume: 26, Issue:7

    Topics: Amikacin; Animals; Anti-Inflammatory Agents; Antioxidants; Disease Models, Animal; Otoacoustic Emissions, Spontaneous; Ototoxicity; Pyruvates; Rats; Rats, Wistar

2022
A Platelet-Rich Plasma-Derived Biologic Clears
    Frontiers in cellular and infection microbiology, 2022, Volume: 12

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Arthritis, Infectious; Biofilms; Biological Products; Disease Models, Animal; Horses; Inflammation; Platelet-Rich Plasma; Staphylococcal Infections; Staphylococcus aureus

2022
The comparative effects of erythromycin and amikacin on acute respiratory Pseudomonas aeruginosa infection.
    Veterinary medicine and science, 2023, Volume: 9, Issue:2

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Disease Models, Animal; Erythromycin; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Respiratory Tract Infections

2023
In vitro and in vivo evaluation of DNase I in reinstating antibiotic efficacy against Klebsiella pneumoniae biofilms.
    Pathogens and disease, 2023, 01-17, Volume: 81

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Biofilms; Cattle; Cefotaxime; Ciprofloxacin; Deoxyribonuclease I; Disease Models, Animal; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests

2023
ORC-13661 protects sensory hair cells from aminoglycoside and cisplatin ototoxicity.
    JCI insight, 2019, 08-08, Volume: 4, Issue:15

    Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Antineoplastic Agents; Cell Culture Techniques; Cells, Cultured; Cisplatin; Disease Models, Animal; Dose-Response Relationship, Drug; Hair Cells, Auditory; Humans; Intravital Microscopy; Ion Channels; Male; Mechanotransduction, Cellular; Mice; Ototoxicity; Patch-Clamp Techniques; Protective Agents; Rats; Thiophenes; Time-Lapse Imaging; Urea; Zebrafish

2019
A recombinant selective drug-resistant M. bovis BCG enhances the bactericidal activity of a second-line anti-tuberculosis regimen.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2021, Volume: 142

    Topics: Amikacin; Animals; Antigens, Bacterial; Antitubercular Agents; BCG Vaccine; Disease Models, Animal; Drug Resistance, Bacterial; Levofloxacin; Mice, Inbred BALB C; Mice, SCID; Mycobacterium bovis; Mycobacterium tuberculosis; Plasmids; Prothionamide; Pyrazinamide; Tuberculosis, Pulmonary; Vaccines, Synthetic; Virulence

2021
Two novel roles of buffalo milk lactoperoxidase, antibiofilm agent and immunomodulator against multidrug resistant Salmonella enterica serovar Typhi and Listeria monocytogenes.
    Microbial pathogenesis, 2017, Volume: 109

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Biofilms; Buffaloes; Cytokines; Disease Models, Animal; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Immunologic Factors; Lactoperoxidase; Listeria monocytogenes; Listeriosis; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Milk; Salmonella typhi; Typhoid Fever

2017
Biological evaluation of diphenyleneiodonium chloride (DPIC) as a potential drug candidate for treatment of non-tuberculous mycobacterial infections.
    The Journal of antimicrobial chemotherapy, 2017, Nov-01, Volume: 72, Issue:11

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Bacterial Load; Chlorocebus aethiops; Disease Models, Animal; Drug Discovery; Kinetics; Meropenem; Mice; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Neutropenia; Nontuberculous Mycobacteria; Onium Compounds; Small Molecule Libraries; Thienamycins; Vero Cells

2017
Therapeutic and protective effects of autologous serum in amikacin-induced ototoxicity.
    The Journal of laryngology and otology, 2018, Volume: 132, Issue:1

    Topics: Amikacin; Animals; Apoptosis; Blood Component Transfusion; Disease Models, Animal; Female; Guinea Pigs; Hearing Disorders; Immunohistochemistry; Otoacoustic Emissions, Spontaneous; Serum; Spiral Ganglion; Treatment Outcome

2018
Amikacin and cefoperazone/sulbactam alone or in combination against carbapenem-resistant Pseudomonas aeruginosa.
    Diagnostic microbiology and infectious disease, 2018, Volume: 91, Issue:2

    Topics: Amikacin; Animals; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cefoperazone; Disease Models, Animal; Drug Therapy, Combination; Female; Humans; Luminescent Measurements; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Sulbactam

2018
Local Delivery of Amikacin and Vancomycin from Chitosan Sponges Prevent Polymicrobial Implant-Associated Biofilm.
    Military medicine, 2018, 03-01, Volume: 183, Issue:suppl_1

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Biofilms; Chitosan; Coinfection; Disease Models, Animal; Mice; Microbial Sensitivity Tests; Vancomycin

2018
Protective effect of pentoxifylline on amikacin-induced ototoxicity.
    Ear, nose, & throat journal, 2018, Volume: 97, Issue:8

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Administration Routes; Drug Administration Schedule; Hearing Loss, Sensorineural; Otoacoustic Emissions, Spontaneous; Pentoxifylline; Phosphodiesterase Inhibitors; Rats; Treatment Outcome

2018
Nebulized Amikacin and Fosfomycin for Severe Pseudomonas aeruginosa Pneumonia: An Experimental Study.
    Critical care medicine, 2019, Volume: 47, Issue:6

    Topics: Administration, Inhalation; Administration, Intravenous; Amikacin; Animals; Anti-Bacterial Agents; Bacterial Load; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fosfomycin; Lung; Meropenem; Nebulizers and Vaporizers; Pneumonia; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Random Allocation; Swine; Trachea

2019
Engraftment of Human Stem Cell-Derived Otic Progenitors in the Damaged Cochlea.
    Molecular therapy : the journal of the American Society of Gene Therapy, 2019, 06-05, Volume: 27, Issue:6

    Topics: Amikacin; Animals; Auditory Threshold; Cell Differentiation; Cell Enlargement; Cell Movement; Cyclosporine; Disease Models, Animal; Fibroblast Growth Factor 10; Fibroblast Growth Factor 3; Guinea Pigs; Hair Cells, Auditory; Hearing Loss; Humans; Immunosuppressive Agents; Induced Pluripotent Stem Cells; Living Donors; Ototoxicity; Stem Cell Transplantation

2019
The Cpx stress response system potentiates the fitness and virulence of uropathogenic Escherichia coli.
    Infection and immunity, 2013, Volume: 81, Issue:5

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Bacterial Proteins; Disease Models, Animal; Escherichia coli Proteins; Gene Expression Regulation, Bacterial; Host-Pathogen Interactions; Humans; Membrane Proteins; Mice; Operon; Protein Kinases; Signal Transduction; Urinary Bladder; Uropathogenic Escherichia coli; Zebrafish

2013
Early vancomycin, amikacin and gentamicin concentrations in pulmonary artery and pulmonary tissue are not affected by VA ECMO (venoarterial extracorporeal membrane oxygenation) in a pig model of prolonged cardiac arrest.
    Pulmonary pharmacology & therapeutics, 2013, Volume: 26, Issue:6

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Disease Models, Animal; Extracorporeal Membrane Oxygenation; Female; Gentamicins; Heart Arrest; Lung; Pulmonary Artery; Swine; Time Factors; Tissue Distribution; Vancomycin

2013
A model portraying experimental loss of hair cell: the use of distortion product otoacoustic emission in the assessment of rat's ear.
    Pakistan journal of pharmaceutical sciences, 2013, Volume: 26, Issue:4

    Topics: Amikacin; Animals; Deafness; Disease Models, Animal; Furosemide; Hair Cells, Auditory; Male; Otoacoustic Emissions, Spontaneous; Rats; Rats, Sprague-Dawley

2013
Protective effect of trimetazidine on amikacin-induced ototoxicity in rats.
    International journal of pediatric otorhinolaryngology, 2014, Volume: 78, Issue:4

    Topics: Amikacin; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Ear, Middle; Evoked Potentials, Auditory, Brain Stem; Female; Hearing Loss; Male; Random Allocation; Rats; Rats, Wistar; Reference Values; Trimetazidine

2014
Delivery of aerosolized liposomal amikacin as a novel approach for the treatment of nontuberculous mycobacteria in an experimental model of pulmonary infection.
    PloS one, 2014, Volume: 9, Issue:9

    Topics: Administration, Inhalation; Aerosols; Amikacin; Animals; Antitubercular Agents; Cell Line; Colony Count, Microbial; Disease Models, Animal; Drug Delivery Systems; Drug Resistance, Bacterial; Female; Humans; Intracellular Space; Liposomes; Lung; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Respiratory Tract Infections

2014
The impact of alpha-lipoic acid on amikacin-induced nephrotoxicity.
    Renal failure, 2015, Volume: 37, Issue:1

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Antioxidants; Blood Urea Nitrogen; Creatinine; Disease Models, Animal; Drug-Related Side Effects and Adverse Reactions; Female; Kidney; Kidney Function Tests; Malondialdehyde; Rats; Rats, Wistar; Renal Insufficiency; Thioctic Acid; Treatment Outcome

2015
Betahistine exacerbates amikacin ototoxicity.
    The Annals of otology, rhinology, and laryngology, 2015, Volume: 124, Issue:4

    Topics: Amikacin; Animals; Betahistine; Cochlea; Disease Models, Animal; Evoked Potentials, Auditory, Brain Stem; Female; Hearing Loss; Injections, Intramuscular; Otoacoustic Emissions, Spontaneous; Rats; Rats, Wistar; Regional Blood Flow; Treatment Outcome; Vasodilator Agents

2015
Joint Intratracheal Surfactant-Antibacterial Therapy in Experimental Pseudomonas-Induced Pneumonia.
    Journal of aerosol medicine and pulmonary drug delivery, 2015, Volume: 28, Issue:4

    Topics: Administration, Inhalation; Amikacin; Animals; Anti-Bacterial Agents; Chemistry, Pharmaceutical; Disease Models, Animal; Drug Carriers; Drug Combinations; Lung; Male; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Pulmonary Surfactants; Rats, Wistar

2015
Pharmacodynamics of nine generic products of amikacin compared with the innovator in the neutropenic mouse thigh infection model.
    BMC research notes, 2015, Oct-07, Volume: 8

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Disease Models, Animal; Escherichia coli Infections; Mice; Neutropenia

2015
Polymicrobial Biofilm Inhibition Effects of Acetate-Buffered Chitosan Sponge Delivery Device.
    Macromolecular bioscience, 2016, Volume: 16, Issue:4

    Topics: Acetates; Amikacin; Animals; Anti-Bacterial Agents; Biofilms; Catheter-Related Infections; Catheters; Chitosan; Delayed-Action Preparations; Disease Models, Animal; Drug Compounding; Drug Liberation; Freeze Drying; Humans; Mice; Polytetrafluoroethylene; Pseudomonas aeruginosa; Skin; Staphylococcus aureus; Vancomycin

2016
Amikacin induced renal damage and the role of the antioxidants on neonatal rats.
    Renal failure, 2016, Volume: 38, Issue:5

    Topics: Amikacin; Animals; Animals, Newborn; Anti-Bacterial Agents; Antioxidants; Disease Models, Animal; Erythropoietin; Kidney Diseases; Kidney Function Tests; Malondialdehyde; Nitric Oxide; Oxidative Stress; Protective Agents; Rats; Rats, Wistar; Treatment Outcome; Vitamin E

2016
Paricalcitol may improve oxidative DNA damage on experimental amikacin-induced nephrotoxicity model.
    Renal failure, 2016, Volume: 38, Issue:5

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Amikacin; Animals; Anti-Bacterial Agents; Bone Density Conservation Agents; Deoxyguanosine; Disease Models, Animal; DNA Damage; Ergocalciferols; Kidney; Kidney Diseases; Kidney Function Tests; Malondialdehyde; Oxidative Stress; Rats; Rats, Wistar; Vascular Endothelial Growth Factor A

2016
A Prospective Experimental Study on the Protective Effect of Resveratrol against Amikacin-Induced Ototoxicity in Rats.
    The journal of international advanced otology, 2016, Volume: 12, Issue:3

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Antioxidants; Disease Models, Animal; Female; Hearing Loss; Otoacoustic Emissions, Spontaneous; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes

2016
Efficacy and pharmacokinetics of ME1100, a novel optimized formulation of arbekacin for inhalation, compared with amikacin in a murine model of ventilator-associated pneumonia caused by Pseudomonas aeruginosa.
    The Journal of antimicrobial chemotherapy, 2017, 04-01, Volume: 72, Issue:4

    Topics: Administration, Inhalation; Amikacin; Animals; Anti-Bacterial Agents; Dibekacin; Disease Models, Animal; Drug Compounding; Lung; Mice; Microbial Sensitivity Tests; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Pseudomonas Infections

2017
[Penetrability of amikacin into prostate tissues in rat models of chronic bacterial prostatitis].
    Zhonghua nan ke xue = National journal of andrology, 2008, Volume: 14, Issue:7

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Disease Models, Animal; Escherichia coli; Injections, Intramuscular; Male; Prostate; Prostatitis; Random Allocation; Rats; Rats, Sprague-Dawley

2008
Comparison of different aminoglycoside antibiotic treatments to refine ototoxicity studies in adult mice.
    Laboratory animals, 2010, Volume: 44, Issue:2

    Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Cochlea; Disease Models, Animal; Dose-Response Relationship, Drug; Evoked Potentials, Auditory, Brain Stem; Gentamicins; Hearing Loss; Kanamycin; Male; Mice; Mice, Inbred C57BL; Mortality; Neomycin

2010
Quantitative assessment of combination antimicrobial therapy against multidrug-resistant bacteria in a murine pneumonia model.
    The Journal of infectious diseases, 2010, Mar-15, Volume: 201, Issue:6

    Topics: Acinetobacter baumannii; Amikacin; Animals; Anti-Bacterial Agents; Cefepime; Cephalosporins; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Lung; Mice; Ofloxacin; Pneumonia, Bacterial; Polymerase Chain Reaction; Pseudomonas aeruginosa; Random Allocation; Survival Analysis

2010
Targeted delivery of amikacin into granuloma.
    American journal of respiratory and critical care medicine, 2010, Dec-15, Volume: 182, Issue:12

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Cells, Cultured; Disease Models, Animal; Drug Delivery Systems; Granuloma; Mice; Microscopy, Fluorescence; Mycobacterium avium; Mycobacterium Infections, Nontuberculous; Neoplasms, Experimental

2010
Local antibiotic delivery using tailorable chitosan sponges: the future of infection control?
    Journal of orthopaedic trauma, 2010, Volume: 24, Issue:9

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Bacterial Infections; Biocompatible Materials; Chitosan; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Fractures, Open; Goats; Infection Control; Pseudomonas Infections; Staphylococcal Infections; Vancomycin

2010
Effect of the combination of clarithromycin and amikacin on Pseudomonas aeruginosa biofilm in an animal model of ureteral stent infection.
    The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:6

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Biofilms; Clarithromycin; Coated Materials, Biocompatible; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Female; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Wistar; Stents; Ureteral Diseases

2011
The optimal aminoglycoside and its dosage for the treatment of severe Enterococcus faecalis infection. An experimental study in the rabbit endocarditis model.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2012, Volume: 31, Issue:10

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Bacterial Load; Disease Models, Animal; Drug Administration Schedule; Drug Evaluation, Preclinical; Endocarditis, Bacterial; Enterococcus faecalis; Female; Gentamicins; Gram-Positive Bacterial Infections; Netilmicin; Rabbits; Time Factors; Tobramycin

2012
Effects of carbapenems and their combination with amikacin on murine gut colonisation by Candida albicans.
    Mycoses, 2013, Volume: 56, Issue:2

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Candida albicans; Candidiasis; Carbapenems; Disease Models, Animal; Drug Therapy, Combination; Gastrointestinal Tract; Humans; Male; Mice

2013
The effects of montelukast against amikacin-induced acute renal damage.
    European review for medical and pharmacological sciences, 2012, Volume: 16, Issue:4

    Topics: Acetates; Acute Disease; Amikacin; Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Blood Urea Nitrogen; Creatinine; Cyclopropanes; Cytoprotection; Disease Models, Animal; Female; Glutathione; Immunohistochemistry; Interleukin-1beta; Kidney; Kidney Diseases; Malondialdehyde; Peroxidase; Quinolines; Rats; Rats, Wistar; Sulfides; Tumor Necrosis Factor-alpha

2012
Changes in projections to the inferior colliculus following early hearing loss in rats.
    Hearing research, 2012, Volume: 287, Issue:1-2

    Topics: Acoustic Stimulation; Age Factors; Amikacin; Animals; Animals, Newborn; Auditory Pathways; Auditory Threshold; Cochlear Nucleus; Disease Models, Animal; Evoked Potentials, Auditory, Brain Stem; Female; Fluorescent Dyes; Hearing Loss; Inferior Colliculi; Male; Neuroanatomical Tract-Tracing Techniques; Neuronal Tract-Tracers; Rats; Rats, Sprague-Dawley; Stilbamidines

2012
Migration and differentiation of mouse embryonic stem cells transplanted into mature cochlea of rats with aminoglycoside-induced hearing loss.
    Acta oto-laryngologica, 2013, Volume: 133, Issue:2

    Topics: Amikacin; Animals; Cell Movement; Cell Survival; Cochlea; Deafness; Disease Models, Animal; Embryonic Stem Cells; Female; Fluorescent Dyes; Green Fluorescent Proteins; Hearing Loss; Immunohistochemistry; Male; Mice; Microscopy, Electron, Scanning; Pregnancy; Pregnancy, Animal; Rats; Rats, Sprague-Dawley; Scala Tympani; Stem Cell Transplantation

2013
Bactericidal activity of rifampin-amikacin against Mycobacterium ulcerans in mice.
    Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:10

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Clarithromycin; Colony Count, Microbial; Disease Models, Animal; Drug Therapy, Combination; Female; Fluoroquinolones; Foot; Mice; Mice, Inbred BALB C; Mycobacterium Infections, Nontuberculous; Mycobacterium ulcerans; Rifampin; Skin Ulcer

2002
Lung deposition and efficiency of nebulized amikacin during Escherichia coli pneumonia in ventilated piglets.
    American journal of respiratory and critical care medicine, 2002, Nov-15, Volume: 166, Issue:10

    Topics: Administration, Inhalation; Amikacin; Animals; Anti-Bacterial Agents; Bronchopneumonia; Disease Models, Animal; Dose-Response Relationship, Drug; Escherichia coli Infections; Injections, Intravenous; Lung; Nebulizers and Vaporizers; Pneumonia, Bacterial; Respiration, Artificial; Severity of Illness Index; Swine; Treatment Outcome

2002
Intravenous treatment of experimental Staphylococcus aureus endophthalmitis: imipenem versus the combination of ceftazidime and amikacin.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2003, Volume: 241, Issue:12

    Topics: Amikacin; Animals; Ceftazidime; Colony Count, Microbial; Disease Models, Animal; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Imipenem; Injections, Intravenous; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vitreous Body

2003
Intravitreal vancomycin and amikacin versus intravenous imipenem in the treatment of experimental Staphylococcus aureus endophthalmitis.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2004, Volume: 242, Issue:4

    Topics: Amikacin; Animals; Disease Models, Animal; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Imipenem; Injections, Intravenous; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vitreous Body

2004
Protective effect of aminoguanidine against nephrotoxicity induced by amikacin in rats.
    Urological research, 2004, Volume: 32, Issue:4

    Topics: Amikacin; Analysis of Variance; Animals; Biopsy, Needle; Disease Models, Animal; Drug Interactions; Female; Guanidines; Immunohistochemistry; Kidney Diseases; Kidney Function Tests; Lipid Peroxidation; Malondialdehyde; Probability; Protective Agents; Random Allocation; Rats; Rats, Wistar; Sensitivity and Specificity

2004
Comparative efficacy of topical gatifloxacin with ciprofloxacin, amikacin, and clarithromycin in the treatment of experimental Mycobacterium chelonae keratitis.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2004, Volume: 122, Issue:8

    Topics: Administration, Topical; Amikacin; Animals; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Cornea; Corneal Ulcer; Disease Models, Animal; Drug Therapy, Combination; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Male; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Ophthalmic Solutions; Rabbits

2004
Pharmacokinetic/pharmacodynamic assessment of the in-vivo efficacy of imipenem alone or in combination with amikacin for the treatment of experimental multiresistant Acinetobacter baumannii pneumonia.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2005, Volume: 11, Issue:4

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Female; Guinea Pigs; Imipenem; Lung; Microbial Sensitivity Tests; Pneumonia, Bacterial

2005
Antibiotic-induced release of inflammatory mediators from bacteria in experimental Klebsiella pneumoniae-induced sepsis.
    Folia microbiologica, 2005, Volume: 50, Issue:2

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Ceftazidime; Disease Models, Animal; Endotoxins; Humans; Inflammation; Klebsiella Infections; Klebsiella pneumoniae; Mice; Ofloxacin; Sepsis; Tumor Necrosis Factor-alpha

2005
In vitro and in vivo synergy of levofloxacin or amikacin both in combination with ceftazidime against clinical isolates of Pseudomonas aeruginosa.
    Journal of chemotherapy (Florence, Italy), 2005, Volume: 17, Issue:4

    Topics: Amikacin; Animals; Ceftazidime; Disease Models, Animal; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; In Vitro Techniques; Levofloxacin; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Sensitivity and Specificity

2005
Clinical doses of amikacin provide more effective suppression of the human CFTR-G542X stop mutation than gentamicin in a transgenic CF mouse model.
    Journal of molecular medicine (Berlin, Germany), 2006, Volume: 84, Issue:7

    Topics: Amikacin; Amino Acid Sequence; Animals; Base Sequence; Codon, Nonsense; Cyclic AMP; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Disease Models, Animal; Gene Expression Regulation; Gentamicins; Humans; Intestinal Mucosa; Intestines; Mice; Mice, Transgenic; Molecular Sequence Data; Protein Biosynthesis

2006
Rapid hair cell loss: a mouse model for cochlear lesions.
    Journal of the Association for Research in Otolaryngology : JARO, 2008, Volume: 9, Issue:1

    Topics: Age Factors; Amikacin; Animals; Anti-Bacterial Agents; Bumetanide; Cell Death; Cell Survival; Cochlear Diseases; Disease Models, Animal; Diuretics; Fluorescent Dyes; Gentamicins; Hair Cells, Auditory, Outer; Kanamycin; Mice; Mice, Inbred CBA; Pyridinium Compounds; Quaternary Ammonium Compounds; Stria Vascularis

2008
Effects of intravitreal corticosteroid in the treatment of Staphylococcus aureus-induced experimental endophthalmitis.
    Retina (Philadelphia, Pa.), 2008, Volume: 28, Issue:2

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Dexamethasone; Disease Models, Animal; Drug Therapy, Combination; Electroretinography; Endophthalmitis; Eye Infections, Bacterial; Female; Glucocorticoids; Imipenem; Injections; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vitreous Body

2008
Comparison of azlocillin, ceftizoxime, cefoxitin, and amikacin alone and in combination against Pseudomonas aeruginosa in a neutropenic-site rabbit model.
    Antimicrobial agents and chemotherapy, 1984, Volume: 25, Issue:5

    Topics: Agranulocytosis; Amikacin; Animals; Anti-Bacterial Agents; Azlocillin; Cefotaxime; Cefoxitin; Ceftizoxime; Disease Models, Animal; Drug Combinations; Female; Hydrogen-Ion Concentration; Kanamycin; Microbial Sensitivity Tests; Neutropenia; Penicillins; Protein Binding; Pseudomonas Infections; Rabbits

1984
Towards a rational approach to the treatment of peritonitis: an experimental study in rats.
    The British journal of surgery, 1984, Volume: 71, Issue:9

    Topics: Amikacin; Ampicillin; Animals; Cephradine; Disease Models, Animal; Injections, Intramuscular; Isotonic Solutions; Male; Metronidazole; Noxythiolin; Peritonitis; Povidone-Iodine; Rats; Rats, Inbred Strains; Rectum; Ringer's Lactate; Therapeutic Irrigation

1984
Relative efficacy of the topical use of amikacin, gentamicin and tobramycin in experimental Pseudomonas keratitis.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 1980, Volume: 15, Issue:1

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Disease Models, Animal; Gentamicins; Guinea Pigs; Keratitis; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin

1980
Antibiotics affecting gastrointestinal colonization of mice by yeasts.
    Journal of chemotherapy (Florence, Italy), 1994, Volume: 6, Issue:1

    Topics: Amikacin; Amoxicillin; Animals; Anti-Bacterial Agents; Candida albicans; Candidiasis; Cefotaxime; Digestive System; Disease Models, Animal; Feces; Gastrointestinal Diseases; Male; Mice; Mice, Inbred ICR; Pefloxacin

1994
Activity of isepamicin and selection of permeability mutants to beta-lactams during aminoglycoside therapy of experimental endocarditis due to Klebsiella pneumoniae CF104 producing an aminoglycoside acetyltransferase 6' modifying enzyme and a TEM-3 beta-l
    The Journal of infectious diseases, 1994, Volume: 169, Issue:6

    Topics: Acetyltransferases; Amikacin; Animals; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactamases; beta-Lactams; Cell Membrane Permeability; Disease Models, Animal; Drug Therapy, Combination; Endocarditis; Female; Gentamicins; Klebsiella pneumoniae; Mutation; Rabbits

1994
Intravitreal pharmacokinetics of liposome-encapsulated amikacin in a rabbit model.
    Ophthalmology, 1993, Volume: 100, Issue:11

    Topics: Absorption; Amikacin; Animals; Disease Models, Animal; Drug Carriers; Endophthalmitis; Eye Infections, Bacterial; Fluorescence Polarization Immunoassay; Half-Life; Liposomes; Rabbits; Random Allocation; Staphylococcal Infections; Staphylococcus aureus; Vitrectomy; Vitreous Body

1993
Comparison of topical antibiotics for treating Mycobacterium fortuitum keratitis in an animal model.
    American journal of ophthalmology, 1993, Dec-15, Volume: 116, Issue:6

    Topics: Administration, Topical; Amikacin; Animals; Ciprofloxacin; Clarithromycin; Colony Count, Microbial; Corneal Stroma; Disease Models, Animal; Drug Therapy, Combination; Eye Infections, Bacterial; Keratitis; Male; Mycobacterium Infections, Nontuberculous; Ophthalmic Solutions; Rabbits; Vancomycin

1993
Salicylate potentiates amikacin therapy in rodent models of Klebsiella pneumoniae infection.
    The Journal of infectious diseases, 1993, Volume: 168, Issue:3

    Topics: Amikacin; Animals; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Klebsiella Infections; Klebsiella pneumoniae; Mice; Neutropenia; Pneumonia; Rats; Rats, Sprague-Dawley; Sodium Salicylate; Survival Analysis

1993
Effects of inflammation and surgery on amikacin levels in the vitreous cavity.
    American journal of ophthalmology, 1993, Jun-15, Volume: 115, Issue:6

    Topics: Amikacin; Animals; Aphakia; Disease Models, Animal; Endophthalmitis; Half-Life; Injections; Lens, Crystalline; Rabbits; Vitrectomy; Vitreous Body

1993
Liposomal amikacin for treatment of M. avium infections in clinically relevant experimental settings.
    Zentralblatt fur Bakteriologie : international journal of medical microbiology, 1996, Volume: 284, Issue:2-3

    Topics: Amikacin; Animals; Body Weight; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Carriers; Granuloma; Injections, Intravenous; Liposomes; Liver Diseases; Male; Mice; Mice, Inbred C57BL; Mice, SCID; Mycobacterium avium; Time Factors; Tuberculosis

1996
Liposomal amikacin: improved treatment of Mycobacterium avium complex infection in the beige mouse model.
    The Journal of antimicrobial chemotherapy, 1996, Volume: 38, Issue:5

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Colony Count, Microbial; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Carriers; Drug Evaluation, Preclinical; Humans; Liposomes; Liver; Mice; Mice, Inbred C57BL; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Random Allocation; Spleen

1996
Experimental pseudomonal posttraumatic endophthalmitis in a swine model. Treatment with ceftazidime, amikacin, and imipenem.
    Retina (Philadelphia, Pa.), 1997, Volume: 17, Issue:2

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Disease Models, Animal; Endophthalmitis; Eye Infections, Bacterial; Eye Injuries, Penetrating; Follow-Up Studies; Imipenem; Injections; Pseudomonas aeruginosa; Pseudomonas Infections; Sclera; Swine; Thienamycins; Vitreous Body

1997
[In vivo pharmacokinetic of amikacin and its pharmacodynamic in combination with cefepime, cefpirome and meropenem in an in vitro/ex vivo micropig model].
    Pathologie-biologie, 1997, Volume: 45, Issue:5

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Cefepime; Cefpirome; Cephalosporins; Disease Models, Animal; Drug Therapy, Combination; Female; Humans; In Vitro Techniques; Klebsiella pneumoniae; Meropenem; Perfusion; Serum Bactericidal Test; Swine; Thienamycins

1997
Therapeutic efficacy of intravitreal ceftazidime, imipenem, and amikacin in a swine model of posttraumatic Pseudomonas aeruginosa endophthalmitis.
    Retina (Philadelphia, Pa.), 1997, Volume: 17, Issue:5

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Disease Models, Animal; Endophthalmitis; Eye Infections, Bacterial; Eye Injuries, Penetrating; Imipenem; Pseudomonas Infections; Swine; Vitreous Body

1997
Cefepime and amikacin synergy in vitro and in vivo against a ceftazidime-resistant strain of Enterobacter cloacae.
    The Journal of antimicrobial chemotherapy, 1998, Volume: 41, Issue:3

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Colony Count, Microbial; Creatinine; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Enterobacter cloacae; Enterobacteriaceae Infections; Lung; Microbial Sensitivity Tests; Pneumonia, Bacterial; Rats; Rats, Mutant Strains; Time Factors; Treatment Outcome

1998
Treatment of experimental pneumonia in rats caused by a PER-1 extended-spectrum beta-lactamase-producing strain of Pseudomonas aeruginosa.
    The Journal of antimicrobial chemotherapy, 1999, Volume: 44, Issue:1

    Topics: Amikacin; Animals; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; Colony Count, Microbial; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Imipenem; Lung; Male; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Wistar

1999
Antinociceptive effect of amikacin and its interaction with morphine and naloxone.
    Pharmacological research, 2000, Volume: 41, Issue:3

    Topics: Acetates; Amikacin; Analgesics; Animals; Disease Models, Animal; Drug Interactions; Injections, Intraperitoneal; Injections, Subcutaneous; Mice; Mice, Inbred BALB C; Morphine; Naloxone; Pain; Pain Threshold

2000
In vivo activity of levofloxacin alone or in combination with imipenem or amikacin in a mouse model of Acinetobacter baumannii pneumonia.
    The Journal of antimicrobial chemotherapy, 2000, Volume: 46, Issue:5

    Topics: Acinetobacter Infections; Amikacin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Area Under Curve; Disease Models, Animal; Drug Therapy, Combination; Female; Imipenem; Levofloxacin; Mice; Mice, Inbred C3H; Microbial Sensitivity Tests; Ofloxacin; Pneumonia, Bacterial; Thienamycins

2000
In vivo efficacy of continuous infusion versus intermittent dosing of ceftazidime alone or in combination with amikacin relative to human kinetic profiles in a Pseudomonas aeruginosa rabbit endocarditis model.
    The Journal of antimicrobial chemotherapy, 2001, Volume: 47, Issue:5

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Colony Count, Microbial; Disease Models, Animal; Endocarditis, Bacterial; Female; Humans; Kinetics; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Rabbits

2001
Comparative penetration of amikacin, gentamicin, and penicillin g into exudate fluid in experimental sterile peritonitis.
    Antimicrobial agents and chemotherapy, 1977, Volume: 11, Issue:1

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Ascitic Fluid; Disease Models, Animal; Gentamicins; Injections, Intravenous; Penicillin G; Peritonitis; Rabbits

1977
[Effect of TFX (Polfa) on the course of experimental bacterial infections in mice treated with ciprofloxacin, amikacin and cefoperazone].
    Pneumonologia i alergologia polska, 1992, Volume: 60, Issue:1-2

    Topics: Amikacin; Animals; Cefoperazone; Ciprofloxacin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Interactions; Drug Therapy, Combination; Escherichia coli Infections; Female; Male; Mice; Mice, Inbred BALB C; Staphylococcal Infections; Staphylococcus aureus; Thymus Extracts

1992
Activity of clarithromycin against Mycobacterium avium complex infection in beige mice.
    Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:11

    Topics: Amikacin; Animals; Anti-Infective Agents; Antitubercular Agents; Clarithromycin; Clofazimine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethambutol; Female; Fluoroquinolones; Humans; Mice; Mice, Inbred C57BL; Mycobacterium avium; Mycobacterium avium Complex; Quinolones; Rifabutin; Rifampin; Rifamycins; Time Factors; Tuberculosis

1992
[Antibiotics of the aminoglycoside group (gentamicin, sisomicin and amikacin) in the prevention and treatment of experimental plague].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 1992, Volume: 37, Issue:5

    Topics: Amikacin; Animals; Culture Media; Disease Models, Animal; Drug Evaluation, Preclinical; Gentamicins; In Vitro Techniques; Injections, Intramuscular; Mice; Plague; Sisomicin; Yersinia pestis

1992
Mycobacterium fortuitum keratitis. A comparison of topical ciprofloxacin and amikacin in an animal model.
    Cornea, 1992, Volume: 11, Issue:6

    Topics: Amikacin; Animals; Ciprofloxacin; Corneal Ulcer; Disease Models, Animal; Eye Infections, Bacterial; Male; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Ophthalmic Solutions; Rabbits; Random Allocation

1992
[Resistance to antibiotic treatment produced in a model of experimental Pseudomonas aeruginosa peritonitis].
    Pathologie-biologie, 1992, Volume: 40, Issue:5

    Topics: Amikacin; Animals; Ceftazidime; Ciprofloxacin; Disease Models, Animal; Drug Resistance, Microbial; Drug Therapy, Combination; Imipenem; Mice; Peritonitis; Pseudomonas aeruginosa; Pseudomonas Infections

1992
Reorganization of auditory cortex after neonatal high frequency cochlear hearing loss.
    Hearing research, 1991, Volume: 54, Issue:1

    Topics: Amikacin; Animals; Animals, Newborn; Auditory Cortex; Cats; Cochlea; Disease Models, Animal; Evoked Potentials, Auditory, Brain Stem; Hearing Loss, High-Frequency; Hearing Loss, Sensorineural

1991
[Comparative study of the effectiveness of amikacin and streptomycin in experimental tularemia].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 1990, Volume: 35, Issue:8

    Topics: Amikacin; Animals; Culture Media; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Francisella tularensis; In Vitro Techniques; Mice; Streptomycin; Tularemia

1990
Treatment of disseminated Mycobacterium avium complex infection of beige mice with liposome-encapsulated aminoglycosides.
    The Journal of infectious diseases, 1990, Volume: 161, Issue:6

    Topics: Amikacin; Animals; Disease Models, Animal; Drug Carriers; Female; Follow-Up Studies; Gentamicins; Liposomes; Liver; Mice; Mice, Inbred C57BL; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Organ Size; Spleen

1990
In vivo and in vitro activity of ciprofloxacin plus azlocillin against 12 streptococcal isolates in a neutropenic site model.
    Diagnostic microbiology and infectious disease, 1987, Volume: 7, Issue:2

    Topics: Amikacin; Animals; Azlocillin; Ciprofloxacin; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Enterococcus faecalis; Female; Gentamicins; Kinetics; Neutropenia; Penicillin G; Rabbits; Streptococcal Infections; Streptococcus; Streptococcus pneumoniae

1987
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 12-08, Volume: 117, Issue:49

    Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection

2020
AdipoRon induces AMPK activation and ameliorates Alzheimer's like pathologies and associated cognitive impairment in APP/PS1 mice.
    Neurobiology of disease, 2022, Volume: 174

    Topics: Adiponectin; Alzheimer Disease; AMP-Activated Protein Kinases; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Cognitive Dysfunction; Disease Models, Animal; Insulin; Insulin Resistance; Mice; Mice, Transgenic; Plaque, Amyloid; Receptors, Adiponectin

2022
AdipoRon mitigates tau pathology and restores mitochondrial dynamics via AMPK-related pathway in a mouse model of Alzheimer's disease.
    Experimental neurology, 2023, Volume: 363

    Topics: Alzheimer Disease; AMP-Activated Protein Kinases; Animals; Disease Models, Animal; Memory Disorders; Mice; Mice, Transgenic; Mitochondrial Dynamics; Neurodegenerative Diseases; tau Proteins; Tauopathies

2023
Multiple myeloma increases nerve growth factor and other pain-related markers through interactions with the bone microenvironment.
    Scientific reports, 2019, 10-02, Volume: 9, Issue:1

    Topics: Adiponectin; Animals; Bone Marrow; Cell Proliferation; Disease Models, Animal; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Mice; Multiple Myeloma; Nerve Growth Factor; Neuroglia; NF-kappa B; Osteoblasts; Pain; Peptides; Piperidines; Quinoxalines; Stromal Cells; Tumor Microenvironment; Tumor Necrosis Factor-alpha

2019
Adiponectin receptor agonist AdipoRon relieves endotoxin-induced acute hepatitis in mice.
    Chinese medical journal, 2019, Oct-20, Volume: 132, Issue:20

    Topics: Acute Disease; Animals; Apoptosis; Caspases; Disease Models, Animal; Galactosamine; Hepatitis; Hepatocytes; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Piperidines; Receptors, Adiponectin; Transforming Growth Factor alpha

2019
The adiponectin receptor agonist AdipoRon normalizes glucose metabolism and prevents obesity but not growth retardation induced by glucocorticoids in young mice.
    Metabolism: clinical and experimental, 2020, Volume: 103

    Topics: Abdominal Fat; Animals; Bone Development; Carbohydrate Metabolism; Disease Models, Animal; Disease Progression; Glucocorticoids; Glucose; Growth Disorders; Male; Mice; Mice, Inbred C57BL; Obesity; Piperidines; Receptors, Adiponectin

2020
AdipoRon improves cognitive dysfunction of Alzheimer's disease and rescues impaired neural stem cell proliferation through AdipoR1/AMPK pathway.
    Experimental neurology, 2020, Volume: 327

    Topics: Alzheimer Disease; AMP-Activated Protein Kinases; Animals; Cell Proliferation; Cognition; Cognitive Dysfunction; Disease Models, Animal; Hippocampus; Mice; Mice, Transgenic; Neural Stem Cells; Piperidines; Receptors, Adiponectin; Signal Transduction

2020
Chronic oral administration of adipoRon reverses cognitive impairments and ameliorates neuropathology in an Alzheimer's disease mouse model.
    Molecular psychiatry, 2021, Volume: 26, Issue:10

    Topics: Administration, Oral; Aged; Alzheimer Disease; Amyloid beta-Peptides; Animals; Cognitive Dysfunction; Disease Models, Animal; Humans; Mice; Mice, Transgenic; Piperidines

2021
AdipoRon, an adiponectin receptor agonist, protects contrast-induced nephropathy by suppressing oxidative stress and inflammation via activation of the AMPK pathway.
    Clinical and experimental nephrology, 2020, Volume: 24, Issue:11

    Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Blood Urea Nitrogen; Cell Adhesion Molecules; Cell Line; Contrast Media; Creatinine; Disease Models, Animal; Inflammation; Iohexol; Kidney Diseases; Lactate Dehydrogenases; Male; Oxidative Stress; Phosphorylation; Piperidines; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Receptors, Adiponectin; Signal Transduction

2020
AdipoRon Protects against Tubular Injury in Diabetic Nephropathy by Inhibiting Endoplasmic Reticulum Stress.
    Oxidative medicine and cellular longevity, 2020, Volume: 2020

    Topics: Animals; Diabetic Nephropathies; Disease Models, Animal; Endoplasmic Reticulum Stress; Humans; Male; Mice; Piperidines

2020
AdipoRon Attenuates Hypertension-Induced Epithelial-Mesenchymal Transition and Renal Fibrosis via Promoting Epithelial Autophagy.
    Journal of cardiovascular translational research, 2021, Volume: 14, Issue:3

    Topics: AMP-Activated Protein Kinases; Animals; Autophagy; Autophagy-Related Protein-1 Homolog; Cell Line; Disease Models, Animal; Epithelial Cells; Epithelial-Mesenchymal Transition; Fibrosis; Humans; Hypertension; Intracellular Signaling Peptides and Proteins; Kidney; Kidney Diseases; Mice, Inbred C57BL; Phosphorylation; Piperidines

2021
Obesity reduces the anticancer effect of AdipoRon against orthotopic pancreatic cancer in diet-induced obese mice.
    Scientific reports, 2021, 02-03, Volume: 11, Issue:1

    Topics: Animals; Cell Line, Tumor; Diet, High-Fat; Disease Models, Animal; Drug Resistance, Neoplasm; Humans; Male; Mice; Obesity; Pancreatic Neoplasms; Piperidines; Receptors, Adiponectin

2021
AdipoRon Attenuates Inflammation and Impairment of Cardiac Function Associated With Cardiopulmonary Bypass-Induced Systemic Inflammatory Response Syndrome.
    Journal of the American Heart Association, 2021, 03-16, Volume: 10, Issue:6

    Topics: Animals; Cardiopulmonary Bypass; Cells, Cultured; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Male; Myocardial Reperfusion Injury; Piperidines; Rats; Rats, Wistar; Systemic Inflammatory Response Syndrome; Ventricular Function

2021
An adiponectin receptor agonist promote osteogenesis via regulating bone-fat balance.
    Cell proliferation, 2021, Volume: 54, Issue:6

    Topics: 3T3 Cells; Animals; Bone and Bones; Bone Regeneration; Cells, Cultured; Disease Models, Animal; Fats; Male; Mice; Osteogenesis; Piperidines; Rats, Sprague-Dawley; Receptors, Adiponectin

2021
Adiponectin receptor agonist AdipoRon ameliorates renal inflammation in diet-induced obese mice and endotoxin-treated human glomeruli ex vivo.
    Diabetologia, 2021, Volume: 64, Issue:8

    Topics: Aged; Aged, 80 and over; Animals; Calcium-Binding Proteins; Cytokines; Diet, High-Fat; Disease Models, Animal; Endotoxins; Female; Humans; Immunoblotting; Immunohistochemistry; Kidney Glomerulus; Lipopolysaccharides; Male; Mice; Mice, Inbred DBA; Mice, Knockout; Middle Aged; Nephritis; Piperidines; Receptors, Adiponectin; Receptors, G-Protein-Coupled; Transcription Factor RelA

2021
AdipoRon, an Orally Active, Synthetic Agonist of AdipoR1 and AdipoR2 Receptors Has Gastroprotective Effect in Experimentally Induced Gastric Ulcers in Mice.
    Molecules (Basel, Switzerland), 2021, May-15, Volume: 26, Issue:10

    Topics: Administration, Oral; Animals; Catalase; Diclofenac; Disease Models, Animal; Ethanol; Male; Mice; Omeprazole; Oxidative Stress; Peroxidase; Piperidines; Receptors, Adiponectin; Stomach Ulcer; Superoxide Dismutase; Treatment Outcome

2021
Activation of Adiponectin Receptor Regulates Proprotein Convertase Subtilisin/Kexin Type 9 Expression and Inhibits Lesions in ApoE-Deficient Mice.
    Arteriosclerosis, thrombosis, and vascular biology, 2017, Volume: 37, Issue:7

    Topics: AMP-Activated Protein Kinases; Animals; Aorta; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Biomarkers; Cholesterol, LDL; Disease Models, Animal; Dose-Response Relationship, Drug; Genetic Predisposition to Disease; Hep G2 Cells; Humans; Hypolipidemic Agents; Liver; Male; Mice, Inbred C57BL; Mice, Knockout; Oligopeptides; Phenotype; Piperidines; Plaque, Atherosclerotic; PPAR gamma; Proprotein Convertase 9; Receptors, Adiponectin; Receptors, LDL; Response Elements; RNA Interference; Signal Transduction; Sterol Regulatory Element Binding Protein 2; Transcriptional Activation; Transfection; Up-Regulation

2017
An orally-active adiponectin receptor agonist mitigates cutaneous fibrosis, inflammation and microvascular pathology in a murine model of systemic sclerosis.
    Scientific reports, 2018, 08-07, Volume: 8, Issue:1

    Topics: Administration, Oral; Animals; Bleomycin; Disease Models, Animal; Female; Fibrosis; Humans; Inflammation; Mice, Inbred C57BL; Piperidines; Receptors, Adiponectin; Scleroderma, Systemic; Signal Transduction; Skin; Vascular System Injuries

2018
Adiporon, an adiponectin receptor agonist acts as an antidepressant and metabolic regulator in a mouse model of depression.
    Translational psychiatry, 2018, 08-16, Volume: 8, Issue:1

    Topics: Animals; Antidepressive Agents; Anxiety; Behavior, Animal; Corticosterone; Cytokines; Depression; Disease Models, Animal; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Piperidines; Receptors, Adiponectin

2018
AdipoRon Attenuates Neuroinflammation After Intracerebral Hemorrhage Through AdipoR1-AMPK Pathway.
    Neuroscience, 2019, 08-01, Volume: 412

    Topics: Adenylate Kinase; Animals; Anti-Inflammatory Agents; Cerebral Hemorrhage; Disease Models, Animal; Encephalitis; Male; Mice; Neurons; Phosphorylation; Piperidines; Receptors, Adiponectin; Signal Transduction

2019
Cell Biology. Ronning after the adiponectin receptors.
    Science (New York, N.Y.), 2013, Dec-20, Volume: 342, Issue:6165

    Topics: Adiponectin; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Obesity Agents; Apoptosis; Ceramidases; Diabetes Mellitus, Experimental; Disease Models, Animal; Hypoglycemic Agents; Insulin Resistance; Mice; Molecular Mimicry; Molecular Targeted Therapy; Obesity; Piperidines; Receptors, Adiponectin

2013